ADMA Biologics Inc (ADMA)

Inventory turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	206,901	169,273	118,815	79,769	61,291
Inventory	US$ in thousands	170,235	172,906	163,280	124,724	81,536
Inventory turnover		1.22	0.98	0.73	0.64	0.75

December 31, 2024 calculation

Inventory turnover = Cost of revenue ÷ Inventory
= $206,901K ÷ $170,235K
= 1.22

The inventory turnover of ADMA Biologics Inc has shown fluctuations over the past five years. In 2020, the inventory turnover was 0.75, indicating that the company's inventory was turned over 0.75 times during that year. This ratio decreased slightly to 0.64 in 2021, suggesting a slower turnover of inventory assets.

However, there was a rebound in inventory turnover in 2022, reaching 0.73, although still below the 2020 level. The trend continued to improve in 2023, with a notable increase in inventory turnover to 0.98, indicating a more efficient management of inventory.

By the end of 2024, ADMA Biologics Inc achieved a significantly improved inventory turnover of 1.22, indicating that the company's inventory was turned over 1.22 times during that year. This increase suggests better inventory management and potentially more effective sales and production processes. Overall, the trend in inventory turnover for ADMA Biologics Inc shows varying levels of efficiency in managing and converting inventory into sales over the past five years.